# Photodynamic Therapy (PDT) With Levulan and Blue Light for the Treatment of Actinic Cheilitis

> **NCT02409732** · PHASE4 · COMPLETED · sponsor: **Dartmouth-Hitchcock Medical Center** · enrollment: 24 (actual)

## Conditions studied

- Actinic Cheilitis

## Interventions

- **DRUG:** aminolevulinic acid hydrochloride
- **PROCEDURE:** Photodynamic therapy with blue light

## Key facts

- **NCT ID:** NCT02409732
- **Lead sponsor:** Dartmouth-Hitchcock Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-04
- **Primary completion:** 2017-07
- **Final completion:** 2017-07
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2018-10-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02409732

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02409732, "Photodynamic Therapy (PDT) With Levulan and Blue Light for the Treatment of Actinic Cheilitis". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02409732. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*